Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) EPS (Basic): 2018-2025

Historic EPS (Basic) for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to -$0.49.

  • Arcturus Therapeutics Holdings' EPS (Basic) fell 88.46% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.46, marking a year-over-year decrease of 5.13%. This contributed to the annual value of -$3 for FY2024, which is 167.86% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its EPS (Basic) stood at -$0.49 for Q3 2025, which was down 44.12% from -$0.34 recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' EPS (Basic)'s 5-year high stood at $4.44 during Q4 2022, with a 5-year trough of -$2.15 in Q1 2021.
  • Over the past 3 years, Arcturus Therapeutics Holdings' median EPS (Basic) value was -$0.52 (recorded in 2025), while the average stood at -$0.50.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' EPS (Basic) plummeted by 276.36% in 2021, and later soared by 402.04% in 2022.
  • Arcturus Therapeutics Holdings' EPS (Basic) (Quarterly) stood at -$1.47 in 2021, then skyrocketed by 402.04% to $4.44 in 2022, then slumped by 109.91% to -$0.44 in 2023, then slumped by 152.27% to -$1.11 in 2024, then crashed by 88.46% to -$0.49 in 2025.
  • Its EPS (Basic) stands at -$0.49 for Q3 2025, versus -$0.34 for Q2 2025 and -$0.52 for Q1 2025.